Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Stock Climbs 14.6 Percent on Q1 Earnings Upgrade

NEW YORK, April 7 (GenomeWeb News) - Shares of Illumina were up 14.58 percent, or $3.22, at $25.30 in afternoon trade after the company projected better-than-expected revenue and earnings for the first quarter.


Also today, investment bank Caris & Company upgraded Illumina's stock to "Above Average" from "Average" today.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.